Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug combo shows promise for tough bladder cancer

NCT ID NCT04879329

Disease control Sponsor: Seagen, a wholly owned subsidiary of Pfizer Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 2 times

Summary

This phase 2 trial is testing whether the drug disitamab vedotin, alone or with pembrolizumab, can shrink tumors in people with advanced bladder cancer that has spread or cannot be removed. The study includes 372 participants whose cancer cells have a protein called HER2. Researchers will also monitor side effects and how the drugs move through the body.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
disitamab vedotin (RC48-ADC) and pembrolizumab (KEYTRUDA)
What this could lead to
If successful, this could provide a new treatment option for people with advanced bladder cancer that has not responded to chemotherapy.
What could go wrong
This is a phase 2 trial, so it is still early. The drugs may not work as hoped or could cause serious side effects. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 372 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2022

Expected to finish

Apr 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Cohorts A and B * Histopathologically-confirmed, locally-advanced, unresectable or metastatic urothelial cancer (LA/mUC), including UC originating from the renal pelvis, ureters, bladder, or urethra * Participants must have received only 1 or 2 lines of prior systemic treatment for LA/mUC, including 1 line of platinum-containing chemotherapy * At least one measurable lesion by investigator assessment based on RECIST version 1.1. * HER2-expression status determined by the central laboratory to be IHC 1+, 2+ or 3+, in the provided tumor sample * Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 Cohort C * Histopathologically-confirmed LA/mUC, including UC originating from the renal pelvis, ureters, bladder, or urethra * No prior systemic therapy for LA/mUC * Neoadjuvant or adjuvant therapy, including PD-(L)1 inhibitors, is acceptable, if disease recurrence/progression occurred more than 12 months after the last dose of systemic therapy * At least one measurable lesion by investigator assessment based on RECIST v1.1. * Participant is eligible to receive cisplatin- or carboplatin- containing chemotherapy per investigator evaluation * HER2-expression status determined by the central laboratory to be IHC 1+, 2+ or 3+, on the provided tumor tissue sample * ECOG performance status of 0, 1, or 2 Cohort D * Histopathologically-confirmed LA/mUC, including UC originating from the renal pelvis, ureters, bladder, or urethra * Based on a participant's eligibility to receive treatment with standard of care therapies in Japan, participants must have received all of the following lines of therapy for LA/mUC: * a. One prior line of platinum-containing chemotherapy. * b. Prior therapy with PD-(L)1 inhibitors as (neo)adjuvant therapy, first-line maintenance therapy or as second line treatment. * c. Prior enfortumab vedotin therapy. * At least one measurable lesion by investigator assessment based on RECIST v1.1. * ECOG performance status of 0 or 1 Cohort E * Histopathologically-confirmed LA/mUC, including UC originating from the renal pelvis, ureters, bladder, or urethra * No prior systemic therapy for LA/mUC * Neoadjuvant or adjuvant therapy, including PD-(L)1 inhibitors, is acceptable, if disease recurrence/progression occurred more than 12 months after the last dose of systemic therapy. * At least one measurable lesion by investigator assessment based on RECIST v1.1. * Participant is eligible to receive cisplatin- or carboplatin- containing chemotherapy per investigator evaluation * HER2-expression status determined by the central laboratory to be IHC 1+, 2+ or 3+, in the provided tumor sample * ECOG performance status of 0 or 1 Cohort G * Histopathologically-confirmed, locally-advanced, unresectable or metastatic urothelial cancer (LA/mUC), including UC originating from the renal pelvis, ureters, bladder, or urethra * Participants must have received only 1 or 2 lines of prior systemic treatment for LA/mUC, including 1 line of therapy containing enfortumab vedotin as monotherapy or in combination with pembrolizumab * The last administration of enfortumab vedotin must be 90 days from the start of study treatment. Intervening therapies are allowed between the final dose of enfortumab vedotin and the start of disitamab vedotin. * At least one measurable lesion by investigator assessment based on RECIST version 1.1. * HER2-expression status determined by the central laboratory to be IHC 1+, 2+ or 3+, in the provided tumor sample * Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 Exclusion Criteria: Cohorts A and B * Known hypersensitivity to disitamab vedotin or any of their components * Prior antitumor treatment (including chemotherapy, radiotherapy, targeted therapy, immunotherapy etc.) within 2 weeks of start of study (defined as Cycle 1 Day 1 for Cohorts A and B) * Toxicity from a previous treatment has not returned to Grades 0 or 1 (except for Grade 2 alopecia) * Prior MMAE-based ADCs (eg, enfortumab vedotin) or HER2-directed therapy * Major surgery that has not fully recovered within 4 weeks prior to dose administration * Peripheral sensory or motor neuropathy ≥ Grade 2 at baseline Cohort C * Known hypersensitivity to disitamab vedotin, pembrolizumab, or any of their components * Prior antitumor treatment (including chemotherapy, radiotherapy, targeted therapy, immunotherapy etc.) within 2 weeks of start of study defined as Cycle 1 Day 1 for the single-arm part of Cohort C and as randomization date for the randomized part of Cohort C) * Toxicity from a previous treatment has not returned to Grades 0 or 1 (except for Grade 2 alopecia) * Prior MMAE-based ADCs (eg, enfortumab vedotin) or HER2-directed therapy * Major surgery that has not fully recovered within 4 weeks prior to dose administration * Peripheral sensory or motor neuropathy ≥ Grade 2 at baseline * Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior the first dose of study drug * Participants who have previously received any prior treatment with an agent directed to another stimulatory or co-inhibitory T cell receptor (including but not limited to CD137 agonists, CAR-T cell therapy, CTLA-4 inhibitors, or OX-40 agonists) are excluded. Cohort D * Known hypersensitivity to disitamab vedotin or any of their components * Prior antitumor treatment (including chemotherapy, radiotherapy, targeted therapy, immunotherapy etc.) within 2 weeks of start of study (defined as Cycle 1 Day 1 for Cohort D) * Toxicity from a previous treatment has not returned to Grades 0 or 1 (except for Grade 2 alopecia) * Prior HER2-directed therapy * Any prior history of ≥ Grade 3 non-hematological AEs related to prior therapy * Major surgery that has not fully recovered within 4 weeks prior to dose administration * Peripheral sensory or motor neuropathy ≥ Grade 1 at baseline Cohort E * Known hypersensitivity to disitamab vedotin, pembrolizumab, or any of their components * Prior antitumor treatment (including chemotherapy, radiotherapy, targeted therapy, immunotherapy etc.) within 2 weeks of start of study (defined as Cycle 1 Day 1 for Cohort E) * Toxicity from a previous treatment has not returned to Grades 0 or 1 (except for Grade 2 alopecia) * Any prior history of ≥ Grade 3 non-hematological AEs related to prior therapy * Prior MMAE-based ADCs (eg, enfortumab vedotin) or HER2-directed therapy * Major surgery that has not fully recovered within 4 weeks prior to dose administration * Peripheral sensory or motor neuropathy ≥ Grade 1 at baseline * Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior the first dose of study drug Cohort G * Known hypersensitivity to disitamab vedotin or any of their components * Prior antitumor treatment (including chemotherapy, radiotherapy, targeted therapy, immunotherapy etc.) within 2 weeks of start of study (defined as Cycle 1 Day 1 for Cohort G) * Toxicity from a previous treatment has not returned to Grades 0 or 1 (except for Grade 2 alopecia) * Prior HER2-directed therapy * Major surgery that has not fully recovered within 4 weeks prior to dose administration * Peripheral sensory or motor neuropathy ≥ Grade 2 at baseline There are additional inclusion and exclusion criteria. The study center will determine if criteria for participation are met.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Urothelial carcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

transitional cell carcinoma Urinary Bladder Neoplasms urothelial carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Urothelial carcinoma

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    176 sites in 8 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AZ Maria Middelares

    ACTIVE_NOT_RECRUITING

    Ghent, 9000, Belgium

  • Accellacare - Deerfield

    RECRUITING

    Deerfield, Illinois, 60015, United States

  • Ankara Universitesi Tip Fakultesi Hastaneleri - Cebeci Arastirma ve Uygulama Hastanesi

    RECRUITING

    Ankara, 06620, Turkey (Türkiye)

  • Arthur J.E. Child Comprehensive Cancer Centre

    RECRUITING

    Calgary, Alberta, T3N 4N1, Canada

  • Atrium Health Cabarrus (biopsy only)

    RECRUITING

    Concord, North Carolina, 28025, United States

  • Atrium Health Mercy (biopsy only)

    RECRUITING

    Charlotte, North Carolina, 28207, United States

  • Atrium Health Union (biopsy only)

    RECRUITING

    Monroe, North Carolina, 28112, United States

  • Atrium Health University City (biopsy only)

    RECRUITING

    Charlotte, North Carolina, 28262, United States

  • Azienda Ospedaliera S. Maria di Terni

    ACTIVE_NOT_RECRUITING

    Terni, 05100, Italy

  • Azienda Ospedaliero Universitaria Pisana

    ACTIVE_NOT_RECRUITING

    Pisa, 56126, Italy

  • BC Cancer - Vancouver

    RECRUITING

    Vancouver, British Columbia, V5Z 4E6, Canada

  • BC Cancer - Vancouver Fairmont Medical Building

    RECRUITING

    Vancouver, British Columbia, V5Z 1H7, Canada

  • Banner Gateway Medical Center

    RECRUITING

    Gilbert, Arizona, 85234, United States

  • Banner MD Anderson Cancer Center

    RECRUITING

    Gilbert, Arizona, 85234, United States

  • Barts Health NHS Trust, St Bartholomew's Hospital

    RECRUITING

    London, EC1A 7BE, United Kingdom

  • Baylor Scott & White Medical Center - Temple

    NOT_YET_RECRUITING

    Temple, Texas, 76508, United States

  • Baylor Scott and White Research Institute

    NOT_YET_RECRUITING

    Dallas, Texas, 75204, United States

  • Beatson West of Scotland Cancer Centre

    RECRUITING

    Glasgow, Scotland, G12 0YN, United Kingdom

  • Beverly Hills Multi-Specialties Practice

    RECRUITING

    Beverly Hills, California, 90211, United States

  • CHU UCL Namur-Site de Saint Elisabeth

    ACTIVE_NOT_RECRUITING

    Namur, 5000, Belgium

  • Cambridge University Hospitals NHS Foundation Trust

    RECRUITING

    Cambridge, CB2 0QQ, United Kingdom

  • Cancer & Hematology Centers of Western Michigan, PC- Kit Storage

    RECRUITING

    Grand Rapids, Michigan, 49546, United States

  • Cancer Care Research Pty Ltd (trading as GenesisCare)

    RECRUITING

    Alexandria, New South Wales, 2015, Australia

  • CancerCare Manitoba

    RECRUITING

    Winnipeg, Manitoba, R3E 0V9, Canada

  • Carolinas Medical Center (biopsy only)

    RECRUITING

    Charlotte, North Carolina, 28203, United States

  • Carolinas Medical Center Investigational Drug Services

    RECRUITING

    Charlotte, North Carolina, 28204, United States

  • Centre integre universitaire de sante et de services sociaux de l'Estrie

    ACTIVE_NOT_RECRUITING

    Sherbrooke, Quebec, J1H 5N4, Canada

  • Centro Medico Austral

    RECRUITING

    CABA, C1019ABS, Argentina

  • Centro Oncologico Korben

    RECRUITING

    Caba, ZC 1426, Argentina

  • Centro de Estudios Clínicos IC La Serena Research

    RECRUITING

    La Serena, Coquimbo Region, 1720430, Chile

  • Centro de Investigaciones Médicas y Desarrollo LC S.R.L

    ACTIVE_NOT_RECRUITING

    Buenos Aires, Buenos Aires F.D., 1113, Argentina

  • Centro di Riferimento Oncologico Di Aviano

    ACTIVE_NOT_RECRUITING

    Aviano, Pordenone, 33184, Italy

  • Chao Family Comprehensive Cancer Center and Ambulatory Care

    RECRUITING

    Irvine, California, 92612, United States

  • Charing Cross Hospital

    RECRUITING

    London, W6 8RF, United Kingdom

  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center)

    ACTIVE_NOT_RECRUITING

    Duarte, California, 91010, United States

  • Clinica Viedma

    RECRUITING

    Viedma, Río Negro Province, R8500ACE, Argentina

  • Diagnostic Medical Group of Southern California (Radiology)

    RECRUITING

    San Gabriel, California, 91776, United States

  • Evelyn H. Lauder Breast and Imaging Centre (BAIC)

    RECRUITING

    New York, New York, 10065, United States

  • Florida Cancer Specialists

    RECRUITING

    Bonita Springs, Florida, 34135, United States

  • Florida Cancer Specialists

    RECRUITING

    Bradenton, Florida, 34205, United States

  • Florida Cancer Specialists

    RECRUITING

    Bradenton, Florida, 34211, United States

  • Florida Cancer Specialists

    RECRUITING

    Cape Coral, Florida, 33909, United States

  • Florida Cancer Specialists

    ACTIVE_NOT_RECRUITING

    Daytona Beach, Florida, 32117, United States

  • Florida Cancer Specialists

    RECRUITING

    Fleming Island, Florida, 32003, United States

  • Florida Cancer Specialists

    RECRUITING

    Fort Myers, Florida, 33905, United States

  • Florida Cancer Specialists

    RECRUITING

    Fort Myers, Florida, 33908, United States

  • Florida Cancer Specialists

    RECRUITING

    N. Venice, Florida, 34275, United States

  • Florida Cancer Specialists

    RECRUITING

    Naples, Florida, 34102, United States

  • Florida Cancer Specialists

    RECRUITING

    Port Charlotte, Florida, 33980, United States

  • Florida Cancer Specialists

    RECRUITING

    Sarasota, Florida, 34232, United States

  • Florida Cancer Specialists

    ACTIVE_NOT_RECRUITING

    Stuart, Florida, 34994, United States

  • Florida Cancer Specialists

    RECRUITING

    Tallahassee, Florida, 32308, United States

  • Florida Cancer Specialists

    RECRUITING

    Venice, Florida, 34285, United States

  • Florida Cancer Specialists

    RECRUITING

    Venice, Florida, 34292, United States

  • Florida Cancer Specialists

    ACTIVE_NOT_RECRUITING

    Vero Beach, Florida, 32960, United States

  • Florida Cancer Specialists

    ACTIVE_NOT_RECRUITING

    Wellington, Florida, 33414, United States

  • Florida Cancer Specialists

    ACTIVE_NOT_RECRUITING

    West Palm Beach, Florida, 33401, United States

  • Florida Cancer Specialists Sarasota Memorial Hospital (SAD)

    RECRUITING

    Sarasota, Florida, 34239, United States

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    ACTIVE_NOT_RECRUITING

    Roma, ROME, 00168, Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    ACTIVE_NOT_RECRUITING

    Roma, 00168, Italy

  • Foothill Cardiology Glendora

    RECRUITING

    Glendora, California, 91741, United States

  • Foothill Cardiology Pasadena

    RECRUITING

    Pasadena, California, 91105, United States

  • Foothill Cardioology

    RECRUITING

    Arcadia, California, 91007, United States

  • Fred Hutchinson Cancer Center

    RECRUITING

    Seattle, Washington, 98109, United States

  • Froedtert Hospital/Medical College of Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

  • GenesisCare - North Shore

    RECRUITING

    St Leonards, New South Wales, 2065, Australia

  • Guy's Hospital

    RECRUITING

    London, SE1 9RT, United Kingdom

  • Harborview Medical Center

    RECRUITING

    Seattle, Washington, 98104, United States

  • Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion)

    RECRUITING

    Detroit, Michigan, 48202, United States

  • Hospital Aleman

    RECRUITING

    Buenos Aires, C1118AAT, Argentina

  • Hospital Sirio Libanes - Buenos Aires

    RECRUITING

    Buenos Aires, ZC 1419, Argentina

  • Hospital Universitari Parc Tauli Sabadell

    ACTIVE_NOT_RECRUITING

    Sabadell, Barcelona, 08208, Spain

  • Hospital Universitari Vall d'Hebrón

    ACTIVE_NOT_RECRUITING

    Barcelona, 08035, Spain

  • Hospital Universitario Virgen del Rocío

    ACTIVE_NOT_RECRUITING

    Seville, 41013, Spain

  • IOV-Istituto Oncologico Veneto IRCCS-U.O. Oncologia Medica 1-SC Farmacia

    ACTIVE_NOT_RECRUITING

    Padova, 35128, Italy

  • IRCCS Ospedale San Raffaele, U.O. Farmacia Studi Clinici

    ACTIVE_NOT_RECRUITING

    Milan, 20132, Italy

  • Icahn School of Medicine at Mount Sinai

    RECRUITING

    New York, New York, 10029, United States

  • Inova Schar Cancer Institute

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • Instituto Medico Especializado Alexander Fleming

    RECRUITING

    Buenos Aires, C1426ANZ, Argentina

  • Instituto Oncologico de Cordoba

    RECRUITING

    Córdoba, X5000, Argentina

  • Izmir Ekonomi Universitesi Medical Point Hastanesi

    RECRUITING

    Izmir, 35575, Turkey (Türkiye)

  • Jewish General Hospital

    RECRUITING

    Montreal, Quebec, H3T 1E2, Canada

  • Kaiser Permanente Alton/Sand Canyon Medical Offices

    RECRUITING

    Irvine, California, 92618, United States

  • Kaiser Permanente Anaheim Kraemer Medical Offices

    RECRUITING

    Anaheim, California, 92806, United States

  • Kaiser Permanente Baldwin Park Medical Center

    RECRUITING

    Baldwin Park, California, 91706, United States

  • Kaiser Permanente Bellflower Medical Offices

    RECRUITING

    Bellflower, California, 90706, United States

  • Kaiser Permanente Fontana Medical Center

    RECRUITING

    Fontana, California, 92335, United States

  • Kaiser Permanente Los Angeles Medical Offices

    RECRUITING

    Los Angeles, California, 90027, United States

  • Kaiser Permanente Ontario Medical Center

    RECRUITING

    Ontario, California, 91761, United States

  • Kaiser Permanente Panorama City Medical Center, Medical Offices 3

    RECRUITING

    Panorama City, California, 91402, United States

  • Kaiser Permanente Riverside Medical Center

    RECRUITING

    Riverside, California, 92505, United States

  • Kaiser Permanente San Diego Mission Road (Regulatory and Lab Supplies)

    RECRUITING

    San Diego, California, 92108, United States

  • Kaiser Permanente San Marcos Medical Offices

    RECRUITING

    San Marcos, California, 92078, United States

  • Kaiser Permanente South Bay Medical center

    RECRUITING

    Harbor City, California, 90710, United States

  • Kaiser Permanente West Los Angeles Medical Center

    RECRUITING

    Los Angeles, California, 90034, United States

  • Kaiser Permanente Woodland Hills Medical Center

    RECRUITING

    Woodland Hills, California, 91367, United States

  • Kaiser Permanente Zion Medical Center

    RECRUITING

    San Diego, California, 92120, United States

  • Karmanos Cancer Institute

    RECRUITING

    Detroit, Michigan, 48201, United States

  • Karmanos Cancer Institute Weisberg Cancer Treatment Center

    RECRUITING

    Farmington Hills, Michigan, 48334, United States

  • Karmanos Cancer Institute at McLaren Greater Lansing

    RECRUITING

    Lansing, Michigan, 48910, United States

  • Levine Cancer Institute

    RECRUITING

    Charlotte, North Carolina, 28204, United States

  • Levine Cancer Institute - Ballantyne

    RECRUITING

    Charlotte, North Carolina, 28277, United States

  • Levine Cancer Institute Concord

    RECRUITING

    Concord, North Carolina, 28025, United States

  • Levine Cancer Institute University

    RECRUITING

    Charlotte, North Carolina, 28262, United States

  • Levine Cancer Institute- Gaston

    RECRUITING

    Gastonia, North Carolina, 28054, United States

  • Lyell McEwin Hospital

    RECRUITING

    Elizabeth Vale, 5112, Australia

  • MD Anderson Cancer Center - Madrid

    ACTIVE_NOT_RECRUITING

    Madrid, 28033, Spain

  • MD Anderson Cancer Center Madrid

    ACTIVE_NOT_RECRUITING

    Madrid, 28033, Spain

  • MSK Basking Ridge

    RECRUITING

    Basking Ridge, New Jersey, 07920, United States

  • MSK Bergen

    RECRUITING

    Montvale, New Jersey, 07645, United States

  • MSK Commack

    RECRUITING

    Commack, New York, 11725, United States

  • MSK Monmouth

    RECRUITING

    Middletown, New Jersey, 07748, United States

  • MSK Wesrchester

    RECRUITING

    Harrison, New York, 10604, United States

  • MSK nassau

    RECRUITING

    Uniondale, New York, 11553, United States

  • Macquarie University

    ACTIVE_NOT_RECRUITING

    Sydney, New South Wales, 2109, Australia

  • Mater Cancer Care Centre, Mater Misericordiae Limited

    RECRUITING

    South Brisbane, Queensland, QLD 4101, Australia

  • Medstar Washington Hospital Center

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • Memorial Sloan Kattering Cancer Centre- Investigational Drug Service Pharmacy

    RECRUITING

    Long Island City, New York, 11101, United States

  • Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street).

    RECRUITING

    New York, New York, 10021, United States

  • Memorial Sloan Kettering Cancer Center - Main Campus

    RECRUITING

    New York, New York, 10065, United States

  • Metro South Hospital and Health Service

    RECRUITING

    Brisbane, Queensland, 4102, Australia

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

  • Moffitt Cancer Center McKinley Hospital

    RECRUITING

    Tampa, Florida, 33612, United States

  • National Cancer Center Hospital East

    ACTIVE_NOT_RECRUITING

    Kashiwa-shi, Chiba, 277-8577, Japan

  • Newport Diagnostics Center (Radiology)

    RECRUITING

    Newport Beach, California, 92660, United States

  • Northwell Health

    ACTIVE_NOT_RECRUITING

    Lake Success, New York, 11042, United States

  • Northwest Georgia Oncology Centers, a Service of Tanner Medical Center Villa Rica

    ACTIVE_NOT_RECRUITING

    Carrollton, Georgia, 30117, United States

  • Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital

    ACTIVE_NOT_RECRUITING

    Cartersville, Georgia, 30121, United States

  • Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital

    ACTIVE_NOT_RECRUITING

    Douglasville, Georgia, 30134, United States

  • Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital

    ACTIVE_NOT_RECRUITING

    Hiram, Georgia, 30141, United States

  • Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital

    ACTIVE_NOT_RECRUITING

    Marietta, Georgia, 30060, United States

  • OSU Wexner Medical Center & James Cancer Hospital

    RECRUITING

    Columbus, Ohio, 43210, United States

  • OU Health Stephenson Cancer Center

    RECRUITING

    Oklahoma City, Oklahoma, 73104, United States

  • OU Medical Center

    RECRUITING

    Oklahoma City, Oklahoma, 73104, United States

  • Ohio State University

    RECRUITING

    Columbus, Ohio, 43210, United States

  • Ohio State University Hospital

    RECRUITING

    Columbus, Ohio, 43210, United States

  • Oncovida SA

    RECRUITING

    Providencia, 8320000, Chile

  • Osaka Prefectural Hospital Organization - Osaka International Cancer Institute

    ACTIVE_NOT_RECRUITING

    Osaka, 541-8567, Japan

  • Osaka University Hospital

    ACTIVE_NOT_RECRUITING

    Suita-shi, Osaka, 565-0871, Japan

  • Ospedale San Raffaele

    ACTIVE_NOT_RECRUITING

    Milan, Lombardy, 20132, Italy

  • Peninsula & South Eastern Haematology and Oncology Group

    ACTIVE_NOT_RECRUITING

    Frankston, Victoria, 3199, Australia

  • Pontificia Universidad Catolica de Chile

    RECRUITING

    Santiago, Providencia, 8330032, Chile

  • Providence Saint Joseph Medical Center

    RECRUITING

    Burbank, California, 91505, United States

  • Rabin medical Center

    RECRUITING

    Petah Tikva, 4941492, Israel

  • Rambam Health Care Campus

    ACTIVE_NOT_RECRUITING

    Haifa, 3109601, Israel

  • Ronald Reagan UCLA Medical Center, Drug Information Center

    RECRUITING

    Los Angeles, California, 90095, United States

  • S.C. Farmacia Interna

    ACTIVE_NOT_RECRUITING

    Terni, 05100, Italy

  • SUNY Upstate Medical University

    ACTIVE_NOT_RECRUITING

    Syracuse, New York, 13210, United States

  • Sapporo Medical University Hospital

    ACTIVE_NOT_RECRUITING

    Sapporo, Hokkaido, 060-8543, Japan

  • Sheba Medical Center

    ACTIVE_NOT_RECRUITING

    Ramat Gan, 52621, Israel

  • Sidney Kimmel Center for Prostate and Urological Cancers - Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 10065, United States

  • Sierra Vista Regional Medical Center

    RECRUITING

    San Luis Obispo, California, 93405, United States

  • Southern California Heart Centers

    RECRUITING

    San Gabriel, California, 91776, United States

  • Southern California Heart Specialists

    RECRUITING

    Pasadena, California, 91105, United States

  • Southern California Permanente Medical Group (SCPMG)

    RECRUITING

    Riverside, California, 92505, United States

  • T.C. Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi

    RECRUITING

    Istanbul, 34722, Turkey (Türkiye)

  • Tel Aviv Sourasky Medical Center

    ACTIVE_NOT_RECRUITING

    Tel Aviv, 6423906, Israel

  • The Cancer & Hematology Centers

    RECRUITING

    Big Rapids, Michigan, 49307, United States

  • The Cancer & Hematology Centers

    RECRUITING

    Grand Rapids, Michigan, 49503, United States

  • The Cancer & Hematology Centers

    RECRUITING

    Grand Rapids, Michigan, 49546, United States

  • The Cancer & Hematology Centers

    RECRUITING

    Holland, Michigan, 49424, United States

  • The Cancer & Hematology Centers

    RECRUITING

    Norton Shores, Michigan, 49444, United States

  • The Cancer Institute Hospital of JFCR

    ACTIVE_NOT_RECRUITING

    Koto-ku, Tokyo, 135-8550, Japan

  • The Chaim Sheba Medical Center

    ACTIVE_NOT_RECRUITING

    Ramat Gan, 5265601, Israel

  • The Christie NHS Foundation Trust

    NOT_YET_RECRUITING

    Manchester, M20 4BX, United Kingdom

  • The Christie NHS Foundation Trust - Christie Hospital

    NOT_YET_RECRUITING

    Manchester, M20 4BX, United Kingdom

  • The Clatterbridge Cancer Centre NHS Foundation Trust, The Clatterbridge Cancer Centre - Wirral

    RECRUITING

    Merseyside, CH63 4JY, United Kingdom

  • The James Cancer Hospital & Solove Research Institute at The OSU Comprehensive Cancer Center

    RECRUITING

    Columbus, Ohio, 43210, United States

  • The James Outpatient Care West Campus

    RECRUITING

    Columbus, Ohio, 43221, United States

  • The University of Chicago Medicine Center for Advanced Care Orland Park

    RECRUITING

    Orland Park, Illinois, 60462, United States

  • The University of Texas MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

  • Tokushima University Hospital

    ACTIVE_NOT_RECRUITING

    Tokushima, Tokushima, 770-8503, Japan

  • Trakya Universitesi Tip Fakultesi Hastanesi (Saglik Arastirma ve Uygulama Merkezi)

    RECRUITING

    Edirne, 22030, Turkey (Türkiye)

  • Twin Cities Community Hospital

    RECRUITING

    Templeton, California, 93465, United States

  • UC Irvine Health

    RECRUITING

    Orange, California, 92868, United States

  • UCLA Burbank Cardiology

    RECRUITING

    Burbank, California, 91505, United States

  • UCLA Cardiovascular Center

    RECRUITING

    Los Angeles, California, 90095, United States

  • UCLA Downtown Los Angeles Primary & Specialty Care

    RECRUITING

    Los Angeles, California, 90017, United States

  • UCLA Encino Specialty Care (Radiology)

    RECRUITING

    Encino, California, 91436, United States

  • UCLA Hematology Oncology

    RECRUITING

    Los Angeles, California, 90095, United States

  • UCLA Hematology Oncology - Porter Ranch

    RECRUITING

    Porter Ranch, California, 91326, United States

  • UCLA Hematology-Oncology Clinic - Santa Clarita

    RECRUITING

    Valencia, California, 91355, United States

  • UCLA Hematology/ Oncology- Pasadena

    RECRUITING

    Pasadena, California, 91105, United States

  • UCLA Hematology/Oncoclogy-Encino

    RECRUITING

    Encino, California, 91436, United States

  • UCLA Hematology/Oncology - Burbank

    RECRUITING

    Burbank, California, 91505, United States

  • UCLA Hematology/Oncology - San Luis Obispo

    RECRUITING

    San Luis Obispo, California, 93401, United States

  • UCLA Hematology/Oncology - Santa Monica

    RECRUITING

    Santa Monica, California, 90404, United States

  • UCLA Hematology/Oncology - Torrance

    RECRUITING

    Torrance, California, 90505, United States

  • UCLA Hematology/Oncology - Ventura

    RECRUITING

    Ventura, California, 93003, United States

  • UCLA Hematology/Oncology - Westlake

    RECRUITING

    Westlake Village, California, 91361, United States

  • UCLA Montecito Primary & Specialty Care

    RECRUITING

    Montecito, California, 93108, United States

  • UCLA Porter Ranch Primary & Specialty Care

    RECRUITING

    Porter Ranch, California, 91326, United States

  • UCLA Santa Clarita Primary & Specialty Care

    RECRUITING

    Valencia, California, 91355, United States

  • UCLA Santa Monica Cardiology

    RECRUITING

    Los Angeles, California, 90404, United States

  • UCLA Simi Valley Alamo Specialty Care

    RECRUITING

    Simi Valley, California, 93065, United States

  • UCLA Thousand Oaks Primary & Specialty Care

    RECRUITING

    Thousand Oaks, California, 91360, United States

  • UCLA Torrance Lomita Specialty Care

    RECRUITING

    Torrance, California, 90505, United States

  • UCLA Ventura Cardiology

    RECRUITING

    Ventura, California, 93003, United States

  • UCLA Westwood Specialty Care

    RECRUITING

    Los Angeles, California, 90095, United States

  • UCSF Cancer Center MZ Phlebotomy

    RECRUITING

    San Francisco, California, 94115, United States

  • UCSF Investigational Drugs Pharmacy

    RECRUITING

    San Francisco, California, 94158, United States

  • UCSF Mount Zion Phlebotomy

    RECRUITING

    San Francisco, California, 94115, United States

  • UCSF Parnassus Phlebotomy

    RECRUITING

    San Francisco, California, 94143, United States

  • UChicago Medicine - River East

    RECRUITING

    Chicago, Illinois, 60611, United States

  • UChicago Medicine Ingalls Memorial

    RECRUITING

    Harvey, Illinois, 60426, United States

  • UChicago Medicine at Ingalls - Flossmoor

    RECRUITING

    Flossmoor, Illinois, 60422, United States

  • UChicago Medicine at Ingalls - Tinley Park

    RECRUITING

    Tinley Park, Illinois, 60477, United States

  • UMass Memorial Medical Center

    RECRUITING

    Worcester, Massachusetts, 01655, United States

  • UNC Hospitals, The University of North Carolina at Chapel Hill

    NOT_YET_RECRUITING

    Chapel Hill, North Carolina, 27514, United States

  • UNC Lineberger Comprehensive Cancer Center / University of North Carolina

    NOT_YET_RECRUITING

    Chapel Hill, North Carolina, 27599, United States

  • University Hospitals Cleveland Medical Center

    RECRUITING

    Cleveland, Ohio, 44106, United States

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94158, United States

  • University of California, San Francisco | HDFCCC - Hematopoietic Malignancies

    RECRUITING

    San Francisco, California, 94158, United States

  • University of Chicago Comprehensive Cancer Center at Silver Cross Hospital

    RECRUITING

    New Lenox, Illinois, 60451, United States

  • University of Chicago Medical Center

    RECRUITING

    Chicago, Illinois, 60637, United States

  • University of Massachusetts Chan Medical School

    RECRUITING

    Worcester, Massachusetts, 01655, United States

  • University of Tennessee Medical Center

    RECRUITING

    Knoxville, Tennessee, 37920, United States

  • University of Washington Medical Center

    RECRUITING

    Seattle, Washington, 98195, United States

  • Valkyrie Clinical Trials

    NOT_YET_RECRUITING

    Los Angeles, California, 90067, United States

  • WellStar Paulding Hospital

    ACTIVE_NOT_RECRUITING

    Hiram, Georgia, 30141, United States

  • West Georgia Infusion Center, a Service of Tanner Medical Center Villa Rica

    ACTIVE_NOT_RECRUITING

    Carrollton, Georgia, 30117, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.